ALBUQUERQUE, N.M. – New technology at Presbyterian Hospital is giving men one more way to face a cancer diagnosis. The ...

We read with great interest the published results of the RADIOSA trial by Giulia Marvaso and colleagues.1 This well designed ...

Scientists conducting medical research are facing an existential crisis: Layoffs and budget cuts pushed by President Trump ...

June brought major prostate cancer updates, and CURE is sharing the latest FDA approvals, label expansions, and emerging data ...

The EpiSwitch PSE next generation blood test uses advances in technology to identify prostate cancer, the most common form of ...

A highly expensive, revolutionary treatment for recurrent prostate cancer is for the first time in Australia available at a ...

Imagine a stadium packed with 75,000 fans, all wearing green and white jerseys—except one person in a solid green shirt.

Homodimer prodrug nanoassemblies (HPNAs) gain significant attention due to their ultrahigh drug-loading capacity and carrier-free nature but suffer from poor self-assembly stability and rapid ...

A man diagnosed with incurable prostate cancer said the news felt like falling into a "black hole", as he urged others to check for signs of the disease. Danny Burkey, from Ossett, was diagnosed ...

SABRE (Copper-64 SAR-Bombesin in Biochemical Recurrence of prostate cancer) was a Phase II multi-centre, single arm, non-randomised, open-label copper-64 labelled SAR-Bombesin PET imaging trial of ...

Many drugs, particularly those used in cancer and other complex diseases, can present with high toxicity or can dissolve poorly, limiting the body's ability to carry it to its destined location ...